pheochromocytoma and its anaesthetic management
TRANSCRIPT
Pheochromocytoma1. Catecholamine
Physiology/Pathophysiology2. Clinical Presentation
1. Epidemiology2. Signs & Symptoms
3. Diagnosis1. Biochemical2. Localization
4. Management1. Preoperative2. Operative3. Postoperative4. Pregnancy
Catecholamine Producing Tumors
Neural Crest
Sympathoadrenal Progenitor Cell(Neuroblasts)
Chromaffin Cell Sympathetic Ganglion Cell
Intra-adrenal Extra-adrenalPheochromocytoma
Ganglioneuroma
Neuroblastoma
Catecholamine Producing TumorsPheochromocytomaParaganglioma (extra-adrenal pheo)GanglioneuromaNeuroblastomaCheodectomaGlomus jugulare tumor
HISTORY First recognised by Von FrankelPheochromocytoma= dusky colored tumorName coined by Pick in 1912Successful surgery for excision of tumor-
Roux & Mayo ( 1926-27)
Pheochromocytoma Neuroendocrine tumour of the medulla
of the adrenal glandsOriginates from the chromaffin cells
along the paravertebral sympathetic chain extending from pelvis to base of skull
>95% are abdominal>90% in adrenal medullaSecretes excessive amounts of
adrenaline and noradrenaline80% occur unilateral
Pheo: ‘Rule of 10’10% extra-adrenal (closer to 15%)10% occur in children10% familial (closer to 20%)10% bilateral or multiple (more if familial)10% recur (more if extra-adrenal)10% malignant10% discovered incidentally
Tyrosine L-Dopa Dopamine
Norepinephrine
Epinephrine
Catecholamines
Normetanephrine
Metaneprine
PNMT
DBH
COMT
COMT
Metabolites
Homovanillic acid(HVA)
MAO, COMT
Vanillymandelic Acid(VMA)
MAO
MAO
TH
phenylethanolamine N-methyltransferase - PNMT
dopamine β-hydroxylase -DBH
Tumor Secretion: Large Pheo: more metabolites (metabolized within tumor before release) Small Pheo: more catecholamines Sporadic Pheo: Norepi > Epi Familial Pheo: Epi > Norepi Paraganglioma: Norepi Cheodectoma, glomus jugulare: Norepi Gangioneuroma: Norepi Malignant Pheo: Dopamine, HVA Neuroblastoma: Dopamine, HVA
Adrenergic ReceptorsAlpha-Adrenergic Receptors
1: vasoconstriction, intestinal relaxation, uterine
contraction, pupillary dilation2: presynaptic NE (clonidine), platelet
aggregation, vasoconstriction, insulin secretion
Beta-Adrenergic Receptors1: HR/contractility, lipolysis, renin secretion 2: vasodilation, bronchodilation, glycogenolysis3: lipolysis, brown fat thermogenesis
Pheochromocytoma
0.01-0.1% of HTN populationFound in 10% of those screened
M = F3rd to 10th decades of lifeRare, investigate only if clinically suspicion:
Signs or SymptomsSevere HTN, HTN crisisRefractory HTN (> 4drugs)HTN present @ age < 20 or > 50 ?Adrenal lesion found on imaging (ex. Incidentaloma)
Pheo: Signs & Symptoms
The five P’s:Pressure (HTN) 9%Pain (Headache) 80%Perspiration 71%Palpitation 64%Pallor 42%
oParoxysms (the sixth P!)The Classical Triad:
Pain (Headache), Perspiration, PalpitationsLack of all 3 virtually excluded diagnosis of pheo
Pheo: Paroxysms, ‘Spells’10- 17%10-60 min durationFrequency: daily to monthlySpontaneousPrecipitated:any activity that displaces abdominal
contentsDiagnostic procedures, I.A. Contrast Drugs (opiods, unopposed -blockade,
anesthesia induction, histamine, ACTH, glucagon, metoclopramide)
Strenuous exercise, movement that increases intra-abdo pressure (lifting, straining)
Micturition (bladder paraganlgioma)
Pheo: Paroxysms, ‘Spells’Sym depend upon the relative proportion of
epi & norepiExcessive secretion of epi & dopamineDue to epinephrine:Headache, profuse sweating, palpitations,
apprehension often with a sense of impending doom
Pallor/flushing d. t peripheral adrenergic response
Due to dopamine:Nausea & vomiting d .t. vasodilation in the GIT
Pheo: Hypotension!Hypotension (orthostatic/paroxysmal)
occurs in many patientsMechanisms:
ECF contractionLoss of postural reflexes due to prolonged
catecholamine stimulationTumor release of adrenomedullin (vasodilatory
neuropeptide)
Cardiac manifestationsSinus tachy, bradycardia , SVT, ventricular
ectopics, V tachCatecholemine induced inc. myocardial
oxygen consumption, coronary vasospasmAngina/MICardiomyopathy- hypertrophic Cardiomyopathy-
diastolic dysfn- norepi inducedDilated cardiomyopathy- systolic dysfn- epi induced CCF with myocarditis concentric hypertrophy/ assymetrical
hypertrophyRarely sinus node dysfunction
Neurologic manifestations Hypertensive encephalopathy ( altered
mental status, focal neurological s/s, seizures )
Stroke – due to cerebral infarction/ embolus
Intracerebral bleed
Pheo: Signs (metabolic) Hypercalcemia
Associated MEN2 HPT PTHrP secretion by pheo
Mild glucose intolerance- supression of insulin secretion, glycogenolysis (↑ norepinephrine)
Epi causes stimulation of insulin release through B2 adrenoceptars- this is offset by the effects of circulation norepinephrine
polyuria Lipolysis- increased epinephrine secr
Weight-loss Ketosis > VLDL synthesis (TG)
Familial PheoMEN 2a
50% Pheo (usually bilateral)+ medullary Ca Thyroid + hyperparathyroidism
MEN 2b50% Pheo (usually bilatl) mucosal neuroma,
marfanoid habitusVon Hippel-Landau
50% Pheo (usually bilat), retinoblastoma, cerebellar hemangioma, nephroma, renal/pancreas cysts
Familial PheoNF1 (Von Recklinghausen's)
2% Pheo (50% if NF-1 and HTN)Café-au-lait spots, neurofibroma, optic glioma
Familial paragangliomaFamilial pheo & islet cell tumorOther: 1.Tuberous sclerosis,2. Sturge-Weber,3. ataxia-telangectgasia, 4.Carney’s Triad (Pheo, Gastric Leiomyoma, Pulm
chondroma)
24h Urine CollectionPositive results (> 2-3 fold elevation):
24h Ucatechols > 2-fold elevation 24h Utotal metanephrines > 1.2 ug/d 24h UVMA > 3-fold elevation
Detected by high performance liquid chromatography
24h Urine CollectionTest Characteristics:
24h urinary catechol Sen 83% Spec 88%24h U total metanephrines Sen 76% Spec 94%24h Ucatechols + Utotal metanephrines Sen 90% Spec 98%24h UVMA Sen 63% Spec 94%
Sensitivity increased if 24h urine collection begun at onset of a paroxysm
Serum creatinine measured for all collections of urine to determine adequacy of collection
Biochemical Tests: SummarySEN SPEC
Ucatechols 83% 88%
Utotal metanephrines 76% 94%
Ucatechols+metaneph 90% 98%
UVMA 63% 94%
Plasma catecholamines 85% 80%
Plasma metanephrines 99% 89%
24h Urine: False PositiveDrugs: TCAs, MAO-i, levodopa, methyldopa,
labetalol, propanolol, clonidine (withdrawal), ilicit drugs (opiods, amphetamines, cocaine), ethanol, sympathomimetics (cold remedies)
Hold these medications for 2 weeks!
Major physical stress (hypoglycemia, stroke, raised ICP, etc.)
Plasma Catecholamines
Plasma total catechols > 2000 pg/mLSEN 85% SPEC 80%
False positives: same as for 24h urine testing, also with diuretics, smoking
Suppression/Stimulation TestingClonidine suppression
Usually they decrease catecholaminesUnlike normals, pheo patients won’t
suppress their plasma norepi with clonidine
Glucagon stimulationMay precipitate hypertensive crisisPheo patients, but not normals, will
have a > 3x increase in plasma norepi with glucagon
Localization: Imaging90% adrenal,
Extra- adrenal sites- organ of Zuckerlandl, bladder, myocardium, mediastenum, carotid & glomus jugulare bodies
CT abdomenAdrenal pheo SEN 93-100%Extra-adrenal pheo SEN 90%
MRI> SEN than CT for extra-adrenal pheo
MIBG ScanSEN 77-90% SPEC 95-100%
MIBG Scan123I or 131I labelled metaiodobenzylguanidine
Saved for cases where pheo diagnosed biochemically but no tumor on CT/ MRI
MIBG catecholamine precurosr taken up by the tumor
Inject MIBG, scan @ 24h, 48h, 72h
False negative scan:Drugs: Labetalol, reserpine, TCAs, phenothiazinesMust hold these medications for 4-6 wk prior to
scan
Pheo ManagementPrior to 1951, reported mortality for
excision of pheochromoyctoma 24 - 50 %HTN crisis, arrhythmia, MI, strokeHypotensive shock
Currently, mortality: 0 - 2.7 %Preoperative preparation, -blockadeNew anesthetic techniques
oAnesthetic agentso Intraoperative monitoring: arterial line,
EKG monitor, CVP line, Swan-GanzExperienced & Coordinated team:
Endocrinologist, Anesthesiologist and Surgeon
Preop Preparation RegimensCombined + blockade
PhenoxybenzamineSelective 1-blocker (ex. Prazosin)Propanolol
Metyrosine
Calcium Channel Blocker (CCB)Nicardipine
Preop: + blockade
Start at least 10-14d preopAllow sufficient time for ECF re-expansion
Phenoxybenzamine Drug of choiceCovalently binds -receptors (1 > 2)Start 10 mg po bid increase q2d by 10-20
mg/dIncrease until BP cntrl and no more
paroxysmsMaintenance 40-80 mg/d (some need > 200
mg/d)
Phenoxybenzamine (cont’d)Side-effect: orthostasis with dosage required to
normalized seated BP, reflex tachycardiaDrawback: periop hypotension/shock unlikely to
respond to pressor agents.Causes presynaptic inhibition of adrenergic control
thus leading to inc in beta adrenergic outflowThus beta blockers needed to be given alongside
Evaluation of adrenergic blockade
Roizens criteriaArterial BP < 160/95 mm Hg in the last 48 hrs
prior to surgery. Recommended to measure in stressful environment
Mild orthostatic hypotension indicates optimal adrenergic blockade but not < 80/45.
ECG- free of ST changes for > 2 wks
Ventricular ectopic < 1 over 5 min
Preop: + blockade-blockade
Used to control reflex tachycardia and prophylaxis against arrhythmia during surgery
Start only after effective -blockade (may ppt HTN)
If suspect CHF/dilated CMY start low dose Propranolol Dose
oStart 40 mg po bid increase to cntrl HR
oUp to 480 mg/day in divided dosesoIV 1-2 mg bolus
Beta adrenergic blockersPropronolol ( contd)
Side effects- may induce cardiac failure, bronchospasm
Oral bioavailability 25% (extensive 1st pass metabolism)
Atenolol- selective B1
Dose 50- 100 mg/d POMax 300 mg/dIV 2.5 to 10 mg/d
Beta adrenergic blockersEsmolol – selective B1 for rapid intraop BP
controlBolus IV 250-500 µ/kg/minInfusion 25 to 250 µ/kg/min
Labetolol –mixed ɑ+ƁDose- 50- 200 mg/d POIV 0.25 mg/kgNot used as asole drug due to unpredictable
control of BP
Preop: + blockadeIf BP still not cntrl despite + blockadeAdd Prazosin to PhenoxybenzaminePrazosin (Minipress) –competitive, selective 1
blockade T1/2- 2-3 HrsDose -1-5 mg PO BDSide effects- postural hypotension reflex
tachycardiaNo blockade required
Not routinely used as incomplete -blockadeUsed more for long-term Rx (inoperable or malignant
pheo)Other selective 1 blockers- terazosin, doxazocin
Other antihypertensivesCCB-
Diltiazem 60- 120mg/d, max 360mg/dT1/2- 3to 5 hrs Side effects- bradycardia, exacerbates
cardiac failure
Nifedepine – 30mg/d PO Max. 360mg/dT1/2-1 to 2 hrsSide effects- hypotension, peripheral edema
ACE-I- Ramipril
Avoid diuretics as already ECF contracted
Preop: CCB
Nicardipine Started po 24h to few weeks preop to cntrl BP and
allow ECF restorationAfter intubation IV Nicardipine gtt (start 2.5
ug/kg/min)IV Nicardipine adjusted to SBPStopped prior to ligation of tumor venous drainageTachycardia Rx with concurrent IV esmolol
Advantage: periop hypotension may still respond to pressor agents as opposed to those patients who are completely -blocked
Preop: + blockadeMeds given on morning of surgeryPeriop HTN:
IV phentolamine (Regitine)Short acting non-selective -blocker
IV Nitroprusside (NTP)Periop arrhythmia: IV esmololPeriop Hypotension: IV crystalloid +/-
colloid
Preop: Metyrosine (Demser)
Synthetic inhibitor of Tyrosine Hydroxylase (TH)Start 250 mg qid max 1 gm qidSevere S/E’s: sedation, extrapyramidal,
diarrhea, nausea/vomit, anxiety, renal/chole stones, galactorrhea
Alone may insufficiently cntrl BP and reported HTN crises during pheo operation
Restrict use to inoperable/malignant pheo or as adjunct to + blockade or other preop prep
Tyrosine L-Dopa Dopamine
Norepinephrine
Epinephrine
PNMT
DBH
TH
O.R.Admit night before for overnight IV salineArterial line, EKG monitor, CVP lineKnown CHF, CAD, low EF(<30): consider Swan-
GanzSpo2, ETCO2, temperature monitoringpreop medications:
Anxiolytic sedative- benzodiazepine helps dec catecholamines release
Opoids- morphine preferably avoided as causes histamine release
Fentanyl, sufentanyl safe
Premedication Atropine or Glyco pyrolate to be omitted-
causes tachycardia
Droperidol- antiemetic, blocks adrenoceptor and inhibit catecholamine uptake & promotes catecholamine release
Anaesthetic technique
General anaesthesiaRegional anaesthesia- mid to low thoracic Combined regional and general anaesthesiaPreferred- combined regional and general
anaesthesia techniqueHere although regional anaesthesia protects
against stresses of surgery, it cannot prevent catecholamine surges due to tumor manipulation.
In extensive sympathetic blockade, severe hypotension after tumor removal,
INDUCTION Essentially imp to give induction agents slowly
along with close monitoring of HR and arterial pressure
Thiopentone / propofol widely usedEtomidate –causes pain/ involuntary movementKetamine – not recommended Multimodal – benzodiazapines+ opoid+
induction agent
Attenuate pressor responseImportant for laryngoscopy and tracheal
intubation 2% lignocaine – 1-1.5mg/kgEsmolol – 50- 100 µg/kg/minDuring laryngoscopy catecholamine levels ↑
Normally- 200- 2000 pg/mlIn pheo- 2000- 20,000 pg/ml
Neuromuscular blockadeNon depolarising neuromusc blocking drugs
DOC-VecuroniumSuxamethonium- avoided causes
fasciculations and rise in intra abdominal pressure
Atracurium/ mivacurium- best avoided d. t release of histamine
Cisatracurium/ rocuronium- safe cardio stable and least histamine release
maintenanceInhalational agent- isoflurane used
extensively coz does not sensitize the myocardium to catecholamines
Halothane undesirable ……arrhythmogenic properties
Sevoflurane used successfully (fast onset …..fast offset)
O.RHave ready: IV phentolamine, IV NTP, IV
esmololOther alternatives tried- MgSO4 ,40-60 mg/kg
bolus foll by 2 gms/hrVery high uncontrolled BP- surgeons to stopLigation of adrenal vein- sudden hypotensionRx hypotension with crystalloid +/- colloid 1st
may need dopamine/ noradrenaline/ phenylephrine
Aim for CVP 12 or Wedge 15Inotropes may not work!
Adverse perioperative effects
Large tumor sizeProlonged duration of surgeryInc levels of preoperative urinary
catecholamines and catecholamine metabolites
PostopPost op ventilation / ICU stay- depends
upon the haemodynamic status…. Preferably ICU stay for 24 hrs
Hypoglycemia post op due to disinhibition of B cell supression….. Increased insulin secretion
Glucose supplementation at end of surgery
Post opMost cases can stop all BP meds postop
Postop hypotension: IV crystalloidHTN free: 5 years 74% 10 years 45%
24h urine collection 2 wk postopSurveillance:
24h urine collections q1y for at least 10yLifelong f/up
5 yr survival- non malignant pheo- 95%Malignant- < 50 %
Pheo: Unresectable, Malignant-blockade
Selective 1-blockers (Prazosin, Terazosin, Doxazosin) 1st line as less side-effects
Phenoxybenzamine: more complete -blockade
-blockerCCB, ACE-I, etc.Nuclear Medicine Rx:
Hi dose 131I-MIBG or 111indium-octreotide depending on MIBG scan or octreoscan pick-up
Sensitize tumor with Carboplatin + 5-FU
Pheo & PregnancyGrave prognosis ,mortility: maternal - 48%, fetal
55%Diagnosis with 24h urine collections and MRINo stimulation tests, no MIBG if pregnantNever spontaneous labour1st & 2nd trimester (< 24 weeks):
Phenoxybenzamine + blocker prepResect tumor laprascopically
3rd trimester:Phenoxybenzamine + blocker prep…..2-3 wksWhen 37 weeks: cesarian section followed by tumor
resection
Conclusion Long term outlook very goodManaged by an experienced team of
anaesthesiologist, surgeon, endocrinologist &cardiologist
Principles of anaesthetic managementGood adrenergic blockade preopVigilent intraop monitoring and treatment of
hyper/ hypotensionPost op ICU care
Antihypertensive for a prolonged period